[Newborn screening of mucopolysaccharidosis type 1]

Record ID 32018015723
Swedish
Original Title: Nyföddhetsscreening för mukopolysackaridos typ 1 (MPS-1)
Authors' objectives: SBU is to assess the reliability of screening methods of mucopolysackaridosis type 1 (PKU screening test), and the effect of the two treatment options currently available in Sweden: hematopoietic stem cell transplantation and enzyme therapy.
Details
Project Status: Ongoing
Anticipated Publish Date: 2026
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Sweden
MeSH Terms
  • Infant, Newborn
  • Neonatal Screening
  • Metabolic Diseases
  • Rare Diseases
  • Mucopolysaccharidosis I
Contact
Organisation Name: Swedish Agency for Health Technology Assessment and Assessment of Social Services
Contact Address: SBU – Swedish Agency for Health Technology Assessment and Assessment of Social Services, P.O. Box 6183, SE-102 33 Stockholm, Sweden. Tel: +46 8 4123200, Fax: +46 8 4113260
Contact Name: registrator@sbu.se
Contact Email: registrator@sbu.se
Copyright: SBU – Swedish Agency for Health Technology Assessment and Assessment of Social Services
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.